SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GENZYME - THE KING OF THE BIOTECHS
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
410 21 0 GENZ
Emcee:  ajcmr Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
185 We have not changed our guidance on the long-term market for Sepra products. TSteve Push-7/25/1997
184 Earnings out .30/share, mean estimate was for .29. Full story merc.comMichael H. Dragon-7/24/1997
183 Steve, I read with great interest Karen Bernstein's article on overly opimiVector1-7/23/1997
182 <<One thing I have been unclear about is the size of the Gaucher's maSteve Push-7/11/1997
181 It appears as if shorts are trying to drive the price down in order to cover prMichael H. Dragon-7/10/1997
180 Vector, An estimated 20,000 people suffer from Gaucher disease in the U.S., buSteve Push-7/6/1997
179 Steve following up from the GENZ thread, you stated <<We are in the proceVector1-7/6/1997
178 At this time, I can't give you a reliable date for introduction of 2nd or 3Steve Push-7/3/1997
177 Thanks for your quick response, Steve.H. Bradley Toland, Jr.-7/1/1997
176 Steve Push Can you release any information on when the 2nd and 3rd generation Curt-7/1/1997
175 All I know about INCERT is what Anika wrote in their press release. These are Steve Push-6/30/1997
174 To: Steve Push Would appreciate any comments you may have in regards to Anika H. Bradley Toland, Jr.-6/30/1997
173 ABIOMED Approves Investment from Genzyme PR News Wire via Dow Jones CSheriff-6/27/1997
172 If Genzyme is even half right about Seprafilm potential 35 in nothing.H. Bradley Toland, Jr.-6/19/1997
171 V1, I am glad to be aboard the GENZ train. I'm holding for that 35. The lCytokine1-6/18/1997
170 Hey Cyto, I have been saying for a while that GENZ is the best risk reward in tVector1-6/18/1997
169 Yes! Great Genzyme movement in recent days.Cytokine1-6/18/1997
168 CharlieS--Just wait till the Seprafilm numbers start rolling in, in addition toH. Bradley Toland, Jr.-6/18/1997
167 Today looks like another nice move on some interesting news. biz.yahoo.com MaCharlieS-6/18/1997
166 Our undervalued stock made a nice move today on good volume. Thanks for your cCytokine1-6/12/1997
165 In the short run (3 years) the market is very inefficient. Genzyme is grossly H. Bradley Toland, Jr.-6/12/1997
164 I supposr the meeting with analyst this am will have a lot to do with how the sMichael H. Dragon-6/12/1997
163 I as perplexed with the stock price as you are. I think the company is undervaVector1-6/12/1997
162 Vector1: I do not understand why GENZ has been weak recently. With today&#Y. Bob Ai-6/12/1997
161 Cytokine and Sheriff, GENZ has been fairly weak recently and I don't think Vector1-6/11/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News